BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE
| Brand name | ONEXTON |
|---|---|
| Active ingredient | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
| Strength | 3.75%;EQ 1.2% BASE |
| Dosage form | GEL |
| Route | TOPICAL |
| Modality | Small molecule |
| FDA approval | November 2014 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8288434 | August 2029 | product |
| 9561208 | June 2029 | product |
| 10220049 | June 2029 | product |
| 9504704 | June 2029 | product |
| 10137142 | June 2029 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.